HANGZHOU TIGERMED CONSULTING CO LTD
(HKEX: 3347)

Hangzhou Tigermed Consulting Co., Ltd. provides clinical research services for research and development of domestic and foreign pharmaceutical and health related products. Its services include technical services for phase I to phase IV clinical trials, registration and declaration of clinical trials, on-site services, as well as data management and analysis, etc. The company was founded on December 15, 2004 and is headquartered in Hangzhou, China.

38.600 -

+0.240 (+0.63%)
Range 37.800 - 38.680   (2.33%)
Open 38.360
Previous Close 38.360
Bid Price 38.580
Bid Volume ('000) 0.2
Ask Price 38.600
Ask Volume ('000) 3.6
Volume ('000) 493.4
Value 18,893,131
Remark -
Delayed prices. Updated at 05 Dec 2025 16:09.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis